Uma publicação de blog

🇬🇧 Multiple Myeloma - The Essentials

Boosting APCL Associação Portuguesa Contra a Leucemia’s clear primer on MM. Myeloma begins in bone-marrow plasma cells and can quietly affect bones, blood counts, and immunity. Good information speeds good decisions - and time matters.
At MYLeukaemia Project, we’re bringing functional precision readouts closer to hospital workflows so clinicians can reach the right therapy sooner.
Kudos to APCL Associação Portuguesa Contra a Leucemia for the continuous education - see the original post below.

🇵🇹 O essencial sobre Mieloma Múltiplo (MM)

A amplificar o excelente conteúdo da APCL Associação Portuguesa Contra a Leucemia. O mieloma inicia-se nos plasmócitos da medula óssea e pode comprometer os ossos, a produção de células do sangue e a imunidade. Informação correta acelera decisões clínicas.
Na MYLeukaemia Project, queremos aproximar resultados de precisão funcional das equipas hospitalares para que a terapêutica certa chegue mais cedo a quem precisa.
Parabéns à APCL Associação Portuguesa Contra a Leucemia pelo trabalho de sensibilização—veja o post original abaixo.

Check the Original post

MYCancer. All rights reserved. © 2026

Subscribe to our newsletter

No Spam. Just occasional product updates & events.

Policies

Privacy Notice

Terms of use

Cookies policy

For Research Use Only. MYLeukaemia is an R&D-stage bone-marrow-on-chip platform. It is not CE-marked as an in vitro diagnostic medical device and is not intended for diagnosis, clinical assessment, patient management or treatment selection. Any future clinical use is subject to analytical and clinical validation and the applicable regulatory conformity route.